School of Medicine
Showing 4,351-4,360 of 4,364 Results
Instructor, Medicine - General Medical Disciplines
Current Research and Scholarly Interests - Improving care and supporting self-management for patients with multiple chronic conditions
- Designing and evaluating innovative health care delivery models for complex and costly patients
- Optimizing health-related technology to personalize and improve care for complex patients and their caregivers
Vinicio de Jesus Perez MD
Assistant Professor of Medicine (Pulmonary and Critical Care Medicine)
Current Research and Scholarly Interests My work is aimed at understanding the molecular mechanisms involved in the development and progression of pulmonary arterial hypertension (PAH). I am interested in understanding the role that the BMP and Wnt pathways play in regulating functions of pulmonary endothelial and smooth muscle cells both in health and disease.
Luis de Lecea
Professor of Psychiatry and Behavioral Sciences
Current Research and Scholarly Interests My lab uses molecular, optogenetic, anatomical and behavioral methods to identify and manipulate the neuronal circuits underlying brain arousal, with particular attention to sleep and wakefulness transitions. We are also interested in the changes that occur in neuronal circuits in conditions of hyperarousal such as stress and drug addiction.
Antoine de Morree
Postdoctoral Research fellow, Neurology and Neurological Sciences
Current Research and Scholarly Interests Molecular mechanisms underlying neuromuscular disorders and the molecular regulation of satellite cell quiescence and activation in relation to normal aging.
Adam de la Zerda
Assistant Professor of Structural Biology and, by courtesy, of Electrical Engineering
Current Research and Scholarly Interests Molecular imaging technologies for studying cancer biology in vivo
Nicholas van Buuren
Postdoctoral Research fellow, Microbiology and Immunology
Current Research and Scholarly Interests Using poliovirus as a model system, the Kirkegaard laboratory has developed a method to decrease the risk of drug-resistance during RNA virus antiviral therapy by targeting dominant drug targets. My goal is to identify equivalent dominant drug targets in hepatitis C virus in order to decrease the risk of drug-resistance during hepatitis C virus antiviral therapy.